Grant to Assist Calorimetry System to market

Following allocation of Horizon 2020 funding, Symcel is preparing the ground for commercialisation of its cell-based assay tool for real-time cellular bioenergetic measurements. The €50,000 grant will fund a feasibility study which forms phase 1 of the Bacterial Analysis and Diagnostics through Growth and Energy in Real-time (Badger) project. This includes a strategic review of the company, its business model visioning and development of an effective business plan.

Magnus Jannsson, Chief Scientific Officer at Symcel commented: “key industry benefits of CalScreener include the fact that it is a high sensitivity, easy to use calorimeter that ensures the fast delivery of reliable information on the type of bacteria involved in infections, enabling a quick choice of individualised patient therapy for hard to diagnose infections. Consequently, once fully commercialised, we believe that our technology is set to have a transformational impact within the healthcare sector.”

Christer Wallin, CEO of Symcel commented: “We are delighted to have been awarded this Phase 1 Horizon 2020 grant and look forward to creating the business plan that will guide our upcoming validation and exploitation efforts. By validating and commercialising CalScreener as a diagnostics tool, the BADGER project will make an important contribution towards fighting antimicrobial resistance in Europe, whilst increasing the level of antibiotic stewardship.”